vTv Therapeutics (VTVT) Total Debt (2014 - 2025)

vTv Therapeutics has disclosed Total Debt across 11 years of filings, most recently posting $328000.0 for Q3 2025.

• In Q3 2025, Total Debt changed N/A year-over-year to $328000.0; the TTM figure through Sep 2025 stood at $328000.0 (changed N/A YoY), while the FY2023 annual figure was $382000.0, down 14.73% from the prior year.
• Total Debt came in at $328000.0 for Q3 2025 at vTv Therapeutics, down from $382000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $4.5 million in Q1 2021 to a low of $328000.0 in Q3 2025.
• Average Total Debt over 4 years is $1.5 million, with a median of $846000.0 recorded in 2022.
• Year-over-year, Total Debt slumped 82.96% in 2022 and grew 19.74% in 2023.
• Over 4 years, Total Debt stood at $1.5 million in 2021, then slumped by 70.49% to $448000.0 in 2022, then retreated by 14.73% to $382000.0 in 2023, then fell by 14.14% to $328000.0 in 2025.
• Per Business Quant data, the three most recent Total Debt figures were $328000.0 in Q3 2025, $382000.0 in Q4 2023, and $473000.0 in Q3 2023.